Significance of NMDA receptor-related glutamatergic amino acid levels in peripheral blood of patients with schizophrenia.
Hypo-function of N-methyl d-aspartate (NMDA) receptors is strongly involved in the brain pathophysiology of schizophrenia. Several excitatory amino acids, such as endogenous glutamate, glycine, serine and alanine, which are involved in glutamate neurotransmission via NMDA receptors, were studied to further understand the pathophysiology of schizophrenia and to find a biological marker for this disease, particularly in peripheral blood. In this literature review, we connect several earlier clinical studies and several studies of excitatory amino acid levels in peripheral blood in a historical context. Finally, we join these results and our previous studies, the Juntendo University Schizophrenia Projects (JUSP), which investigated plasma glutamatergic amino acid levels in detail, and considered whether these amino acid levels may be diagnostic, therapeutic, or symptomatic biological markers. This review concludes that peripheral blood levels of endogenous glycine and alanine could be a symptomatic marker in schizophrenia, while peripheral blood levels of exogenous glycine and alanine in augmentation therapies could be therapeutic markers. Noteworthy peripheral blood levels of endogenous d-serine could reflect its brain levels, and may prove to be a useful diagnostic and therapeutic marker in schizophrenia. In addition, measurements of new endogenous molecules, such as glutathione, are promising. Finally, for future therapies with glutamatergic agents still being examined in animal studies, the results of these biological marker studies may lay the foundation for the development of next-generation antipsychotics.
Ohnuma
Tohru
T
Department of Psychiatry, Juntendo University Schizophrenia Projects, Juntendo University, School of Medicine, Tokyo, Japan. tohru.oonuma@nifty.ne.jp
Arai
Heii
H
D000596:Amino Acids / Q000097:blood*; D014150:Antipsychotic Agents / Q000494:pharmacology / Q000627:therapeutic use; D018698:Glutamic Acid / Q000097:blood; D006801:Humans; D016239:MEDLINE / Q000706:statistics & numerical data; D009752:Nutritional Status / Q000502:physiology; D016194:Receptors, N-Methyl-D-Aspartate / Q000378:metabolism*; D012559:Schizophrenia / Q000097:blood* / Q000188:drug therapy
D000596:Amino Acids; D014150:Antipsychotic Agents; D016194:Receptors, N-Methyl-D-Aspartate; D018698:Glutamic Acid